How to Invalidate a Patent: U.S. Options, Standards, and Smart Strategy

A weak patent can block your product, drain your budget, chill investment, or create uncertainty around a launch, licensing deal, or acquisition. The good news is that U.S. law gives businesses, inventors, and accused infringers several precise tools to challenge an issued patent.

But learning how to invalidate a patent isn’t just about finding one piece of prior art and filing a challenge. The right strategy depends on the timing, grounds for invalidity, available evidence, burden of proof, and the forum in which the challenge will be heard.

At Goldstein Patent Law, we often see business owners focus on the wrong first question. They ask, “How do I knock out this patent?” when the better starting point is, “Does this patent actually cover the product or activity I am worried about, and if it does, where is it vulnerable?”

This guide explains each major U.S. path, shows when each option is appropriate, and highlights practical steps real teams use to challenge weak patents.

Attorney insight: Patent invalidation is a strategy decision, not a single tactic. Before attacking a patent, confirm the exact patent number, owner, status, claims, priority date, and whether the patent actually covers the product or activity at issue.

TL;DR: How to Invalidate a Patent

• You can challenge a U.S. patent in court or at the USPTO.
• Many businesses start with the Patent Trial and Appeal Board (PTAB) if the timing and grounds fit.
• Inter partes review (IPR) is fast and focused, but it’s limited to prior patents and printed publications under novelty or obviousness.
• Post-grant review (PGR) has a short 9-month window after the grant, but it allows broader challenges, including Section 101 and Section 112 issues.
• Ex parte reexamination is an anytime, paper-only route limited to patents and printed publications.
• District court allows broader evidence, including public use, prior use, sales activity, on-sale bar evidence, and certain equitable defenses.
• Courts apply a higher burden of proof than the PTAB, so forum selection matters.
• Before choosing a path, check deadlines, estoppel risk, claim construction, and whether the alleged patent actually covers the product.

First Principles: What Makes a Patent Invalid?

Under U.S. law, a granted patent is presumed valid. That doesn’t mean it’s bulletproof. A patent can be invalidated if one or more claims fail to satisfy the statutory requirements for patentability.

Common invalidity grounds include:

• Section 101: Patent eligibility. The claim covers subject matter that isn’t patent-eligible, such as an abstract idea lacking sufficient technical substance.
• Section 102: Lack of novelty. A single prior art reference discloses every element of the claimed invention.
• Section 103: Obviousness. The claimed invention would have been obvious to a person of ordinary skill in the art in view of the prior art. The Supreme Court’s Graham factors and KSR decision shape this analysis.
• Section 112: Written description, enablement, or indefiniteness problems. The patent doesn’t describe the invention adequately, doesn’t teach others how to make and use it, or fails to inform skilled artisans about the scope of the claim with reasonable certainty.
• Inventorship issues. A patent may be vulnerable if the wrong inventors were named, although incorrect inventorship can sometimes be corrected and doesn’t automatically invalidate every patent.
• Priority problems. A break in the priority chain can expose the patent to prior art that would not otherwise apply.
• On-sale or public-use activity. Prior sales, offers for sale, or public use may render a later-issued patent invalid, even when the later-issued patent appears valid on its face.

Important timing note: The modern prior-art rules in the America Invents Act (AIA) apply to patents with an effective filing date on or after March 16, 2013. Pre-AIA rules may govern older patents. Always check which regime applies.

Start Here: Does the Patent Actually Cover the Product?

Before spending money on a patent invalidity challenge, verify that the patent actually matters. Sometimes a competitor promotes a product as “patented,” but the patent doesn’t actually cover the feature you care about.

In other situations, the product may be covered by a pending application, an expired patent, a design patent rather than a utility patent, or no patent at all. A practical first-pass review should answer:

1. What is the exact patent number?
2. Who owns the patent?
3. Is the patent active, expired, abandoned, or subject to terminal disclaimers or maintenance-fee issues?
4. Which specific claims supposedly cover the product or activity?
5. Does each claim element map onto the product?
6. What is the patent’s priority date?
7. Are there related parent, continuation, continuation-in-part, or divisional applications?

This step can prevent wasted effort. In some cases, the better strategy isn’t to invalidate the patent at all. It may be to show non-infringement, design around the claims, seek a license, challenge only the most relevant claims, or document a freedom-to-operate position.

What Is a Patent Invalidity Search?

A patent invalidity search is a focused search for prior art to challenge the validity of an issued patent.

The goal is to find information that the USPTO examiner may not have considered during prosecution, or to find prior art that is more relevant than what appears in the patent’s file history. Strong invalidity searches usually include:

• U.S. patents and published applications
• Foreign patents and published applications
• Scientific literature
• Product manuals
• Standards documents
• Technical papers
• Archived web pages
• Conference materials
• Sales materials or product documentation, which are usable in the selected forum
• Citations from related patents and cited-by references
• The patent’s prosecution history, sometimes called the file wrapper

The strongest prior art doesn’t merely resemble the invention at a high level. It maps directly to the claim language. A useful invalidity search should therefore result in a claim chart showing where each claim limitation appears in the prior art.

Where to Challenge a Patent

There are several ways to challenge a U.S. patent. The best route depends on what evidence you have, whether you have been sued, how old the patent is, and whether you can live with the estoppel risk.

District Court Litigation

In an infringement lawsuit, the accused infringer can assert invalidity as a defense. Because the patent is presumed valid, the challenger must prove invalidity by clear and convincing evidence.

Courts construe claims under the Phillips standard, which looks to the ordinary meaning of the claim terms in light of the specification and prosecution history. For indefiniteness under Section 112(b), a claim is invalid if it fails to inform skilled artisans about the scope of the invention with reasonable certainty.

District court is especially important when the invalidity case depends on evidence that cannot be used in IPR, such as public use, prior use, commercial activity, sales records, offers for sale, or certain inequitable conduct defenses.

Best when:

• You need non-publication evidence, such as public use, on-sale activity, prior use, or contracts.
• You are already defending an infringement lawsuit.
• The PTAB window has closed.
• IPR or PGR grounds are too narrow for the facts.
• You need remedies or defenses that the PTAB cannot provide.

Patent Trial and Appeal Board (PTAB)

The Patent Trial and Appeal Board (PTAB) is an administrative tribunal within the USPTO that handles several patent validity proceedings, including IPR and PGR.

One important difference between federal court and PTAB proceedings is that the district court generally requires a real “case or controversy”. PTAB proceedings don’t require the same type of live infringement dispute as district court proceedings. A challenger can file a petition with the PTAB requesting review of patentability if the statutory requirements are met.

That difference matters. A business that hasn’t yet been sued may still have a PTAB option, depending on timing, grounds, and statutory bars.

Inter Partes Review (IPR)

Inter partes review is a trial-like PTAB proceeding that challenges issued patent claims under Sections 102 and 103, using only prior art patents or printed publications.

For first-inventor-to-file patents, an IPR petition generally must be filed after the later of:

• 9 months after the patent issues; or
• the end of any post-grant review.

If you were served with a district-court complaint alleging infringement of the patent, the IPR petition must be filed within 1 year of that service. The 9-month/PGR timing limits don’t apply to older first-to-invent patents, although the 1-year bar after service of an infringement complaint still applies.

The PTAB applies the same claim-construction approach used by courts, the Phillips standard. But the burden of proof is lower than in court: the petitioner must prove unpatentability by a preponderance of the evidence, meaning more likely than not.

By statute, the PTAB generally aims to issue a final written decision within 1 year of institution. Estoppel attaches after a final written decision, which can bar the petitioner from later raising in court grounds that were raised or reasonably could have been raised in the IPR.

Best when:

• Strong prior art, such as a patent or printed publication, supports a novelty or obviousness challenge.
• You want a specialized forum with a lower burden than the district court.
• You were sued and can file before the 1-year bar.
• You are comfortable including all reasonably available publication-based grounds because of the estoppel risk.

Post-Grant Review (PGR)

Post-grant review is broader than IPR but has a short deadline. A PGR petition must be filed within 9 months of the patent’s grant or reissue.

PGR can raise broader invalidity grounds than IPR, including:

• Section 101 patent eligibility
• Section 102 novelty
• Section 103 obviousness
• Section 112 written description, enablement, or indefiniteness issues, except best mode

Like IPR, PGR uses the preponderance standard and the Phillips claim construction standard. PGR is available only for AIA patents, meaning patents with an effective filing date on or after March 16, 2013.

Best when:

• The patent has just been issued.
• You need to raise Section 101 or Section 112 issues.
• The patent has functional claiming, unclear boundaries, or a thin technical disclosure.
• You want to challenge the patent before it becomes a larger business or litigation problem.

Ex Parte Reexamination

Any person can request ex parte reexamination at any time during a patent’s enforceability period. The request must be based on patents or printed publications and must raise a substantial new question of patentability.

Unlike IPR or PGR, the requester doesn’t participate after filing. The proceeding is primarily between the patent owner and the USPTO.

For unexpired patents, examiners apply the broadest reasonable interpretation standard, which can make claims easier to read on prior art. For expired patents in reexamination, Phillips-style claim construction applies because the claims cannot be amended. Ex parte reexamination is limited in scope and doesn’t allow on-sale, public-use, or prior-use evidence.

Best when:

• You have strong prior art in the form of printed publications.
• You missed IPR deadlines.
• Budget is a major concern.
• You want a lower-profile option.
• You can accept limited participation after filing.

Finding Your Best Legal Strategy 

Choosing the right path to challenge a competitor’s claim requires weighing multiple legal strategies to determine which aligns best with your budget and timeline. Evaluating these critical differences helps you make a confident, calculated decision that safeguards your business investments and clears your path forward in the United States marketplace.

What Evidence Works?

The evidence you can use depends heavily on the forum.

Printed Prior Art

Patents, published patent applications, journal articles, technical papers, standards documents, product manuals, and other printed publications can support IPR, PGR, ex parte reexamination, and district-court invalidity defenses.

Non-Publication Evidence

Public use, sales, offers for sale, prior use, contracts, invoices, marketing records, user logs, and product release materials can be powerful evidence in district court and, within the 9-month window, PGR.

These forms of evidence are not available in IPR, which is limited to patents and printed publications.

Case Spotlight: Helsinn v. Teva and the On-Sale Bar

One of the most important lessons for anyone learning how to invalidate a patent is that prior art is not limited to old patents and academic papers.

In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., the Supreme Court confirmed that a commercial sale can trigger the on-sale bar even when some details of the invention are kept confidential. In practice, a confidential business deal can still raise patent validity issues if it meets the legal requirements for the on-sale bar.

That is why patent invalidity work shouldn’t stop with publication searches. In the right forum, the investigation should also look at:

• supply agreements
• distribution agreements
• purchase orders
• invoices
• term sheets
• investor materials
• beta tests
• public demonstrations
• product launch records
• archived marketing pages

Practical takeaway: If a product or invention was commercially offered, sold, used publicly, or disclosed before the critical date, that evidence may become central to invalidating the patent.

Priority Chain Problems: When the Filing Date Falls Apart

A patent’s priority date can determine what counts as prior art. That makes the priority chain a critical part of any invalidity analysis.

A break in the priority chain occurs when a later application fails to maintain continuity with an earlier one. This can happen with continuations, divisionals, continuation-in-part applications, provisional applications, or foreign priority claims.

If the priority claim fails, the patent may lose the benefit of the earlier filing date. That can expose the claims to additional prior art.

For example, imagine a patent claims priority to a provisional application filed in 2020, but the provisional doesn’t adequately describe the claimed feature. If the later non-provisional application was filed in 2021, prior art from between those dates may become available against the claim.

Practical takeaway: Don’t assume the priority date printed on the face of the patent applies to every claim. Review the full family history and confirm whether the earlier filing actually supports each challenged claim.

Inventorship and the Inventor’s Declaration

During the patent application process, inventors must sign an oath or declaration identifying the true inventors. Inventorship matters because U.S. patents are tied to the people who actually conceived the claimed invention.

Inventorship problems can arise when:

• A contributor was left off the patent;
• A person was listed even though they didn’t contribute to the claimed invention;
• Business founders, investors, engineers, or product team members were added for business reasons rather than inventive contribution; or
• Different claims have different true inventors.

This issue should be handled carefully. Incorrect inventorship doesn’t automatically invalidate every patent in every situation, and U.S. law may allow correction in some circumstances. But when inventorship errors are tied to deceptive intent, ownership disputes, missing assignments, or inaccurate declarations, they can become strategically important.

Practical takeaway: Invalidation analysis should include inventor declarations, assignments, employment records, lab notebooks, product-development records, and communications showing who actually conceived the claimed subject matter.

How Often Does the PTAB Invalidate Patents?

Patent challenges at the PTAB aren’t theoretical. A prior analysis cited by US Inventor reported that, among patents in its dataset that reached a PTAB Final Written Decision, 3,000 of 3,572 were determined to be “Unpatentable/Canceled”.

That statistic should be used carefully. It doesn’t mean every challenged patent has an 84% chance of being invalidated, nor does it account for every patent that settles, avoids institution, or is never challenged. However, it does show why issued patents should not be treated as automatically untouchable.

Practical takeaway: Granted, patents can be invalidated, but the odds depend on the claims, prior art, forum, timing, and quality of the petition or defense.

Examples

Real case scenarios demonstrate how to invalidate a patent using tactical evidence, giving you a clear picture of how to protect your own company’s freedom to operate.

Beating a Broad Software Claim With IPR

A competitor sues a SaaS company on a data-sync patent. The defendant identifies two published standards documents and an earlier patent that, together, disclose every step of the challenged claims.

Because the art consists solely of publications, and the suit was served 4 months ago, the team files an IPR before the 1-year bar. The PTAB institutes obviousness review, applies Phillips claim construction, and cancels the challenged claims under a preponderance-of-the-evidence standard.

Estoppel attaches, but the team has already neutralized the key claims and has won a stay in court pending the PTAB’s outcome.

Using PGR to Raise Section 112

A newly issued medical device patent includes functional claims with unclear boundaries and sparse technical detail. Within 9 months of the grant, a competitor files a PGR alleging indefiniteness, lack of written description, and obviousness.

The PTAB institutes review because at least one challenged claim is more likely than not unpatentable. On the final decision, several claims fall under Section 112, and others fall as obvious.

The broader PGR grounds avoided a longer, more expensive court fight focused only on 102 and 103.

Finding Out the Product Is Not Covered

A startup pauses a launch after seeing a competitor advertise a “patented” product. After reviewing the patent claims, the team discovers that the patent covers a narrow mechanical feature that the startup’s product doesn’t use.

The team doesn’t need to invalidate the patent. Instead, it documents a non-infringement position and adjusts marketing language to reduce risk.

The lesson: sometimes the best invalidation strategy is first proving that invalidation is unnecessary.

Actionable Checklist: How to Invalidate a Patent

Following a structured sequence systematically dismantles an opponent’s legal hold, giving your enterprise a distinct competitive edge.

1. Map the Timeline

Identify the patent’s grant date, effective filing date, priority claims, expiration date, and any complaint service date. Calendar the PGR 9-month window and the IPR 1-year bar from service.

2. Confirm the Patent Actually Matters

Map the asserted claims to the product or activity. Confirm whether the patent is active, enforceable, and relevant to the business problem.

3. Pick the Right Forum

If you need Section 101, Section 112, or non-publication evidence, consider PGR if still available or the district court. If you have strong patents or printed publications, consider IPR or ex parte reexamination.

4. Lock Down Prior Art

Build a focused claim chart for each challenged claim. Preserve web captures, publication dates, metadata, and copies of all references.

5. Investigate Commercial Activity

Collect contracts, invoices, purchase orders, product announcements, beta-test materials, investor decks, user logs, and marketing records. Helsinn confirms that even confidential commercial activity can matter.

6. Review the Priority Chain

Check parent applications, provisional applications, continuations, continuations-in-part, divisionals, and foreign priority claims. Confirm that the earlier applications actually support the challenged claims.

7. Review Inventorship and Ownership

Check inventor declarations, assignments, employment agreements, contractor agreements, and development records. Determine whether the listed inventors match the claimed invention.

8. Plan for Claim Construction

Frame key terms under Phillips using the specification and prosecution history. In ex parte reexamination, remember that broader claim interpretation may apply.

9. Budget for Estoppel

In IPR and PGR, include all reasonably available grounds that you may need later. Estoppel after a final written decision can be sweeping.

10. Coordinate Parallel Tracks

If sued, consider seeking a stay of litigation after PTAB institution. Avoid duplicating grounds that may later become estopped.

Glossary

Familiarizing yourself with key legal terms shields your business from confusion and keeps you from feeling intimidated during complex legal proceedings.

• Prior Art: Public information before the patent’s effective filing date that can defeat novelty or show obviousness.
• Patent Invalidity Search: A search for prior art or other evidence that can be used to challenge an issued patent.
• Obviousness: A claim is invalid if, in view of the prior art, it would have been obvious to a skilled person.
• Phillips Standard: A claim-construction standard that interprets claim terms by their ordinary meaning in light of the specification and prosecution history.
• Preponderance of the Evidence: More likely than not. This is the PTAB’s burden of proof for unpatentability.
• Clear and Convincing Evidence: A higher burden used in district court to prove patent invalidity.
• Estoppel: A rule that can bar a losing IPR or PGR petitioner from raising grounds that were or reasonably could have been raised.
• On-Sale Bar: A rule under which prior commercial sales or offers can invalidate later-filed patent claims, even when some details of the sale were confidential.
• Priority Chain: The chain of earlier applications that a patent relies on for its effective filing date.
• Substantial New Question of Patentability: The threshold for ordering ex parte reexamination based on patents or printed publications.

FAQ

How do you invalidate a patent?

You invalidate a patent by proving that one or more claims should not have been granted under U.S. patent law. Common routes include district court litigation, inter partes review, post-grant review, and ex parte reexamination. The best path depends on the patent’s age, your evidence, and whether you need to raise prior art, eligibility, written description, enablement, inventorship, priority, public-use, or on-sale issues.

Is IPR cheaper and faster than the court?

Generally, IPR is faster and more focused than district court litigation. The PTAB targets a 1-year decision timeline after institution and applies a lower burden of proof than the district court. But IPR is limited to patents and printed publications and can create significant estoppel risk.

Can I use on-sale or public-use evidence in IPR?

No. IPR is limited to patents and printed publications under Sections 102 and 103. If your best evidence involves sales, offers for sale, public use, prior use, contracts, or commercial activity, consider PGR if it is still available, or raise those defenses in district court.

What if the patent has just been issued?

Consider post-grant review within 9 months of the patent’s grant or reissue. PGR allows broader challenges, including Section 101 and Section 112 issues, in addition to novelty and obviousness.

Can a confidential sale invalidate a patent?

Yes, in some circumstances. The Supreme Court’s Helsinn v. Teva decision confirmed that a commercial sale can trigger the on-sale bar even when certain details are confidential. That is why invalidity investigations should include contracts, invoices, supply agreements, and other commercial records when the forum allows that evidence.

Can incorrect inventorship invalidate a patent?

Inventorship issues can create serious patent problems, especially when they involve deceptive intent, ownership disputes, or inaccurate declarations. But incorrect inventorship can sometimes be corrected, so this issue needs careful legal analysis.

What is a break in the priority chain?

A break in the priority chain occurs when a later patent application fails to claim or support priority to an earlier application properly. If the priority claim fails, additional prior art may become available, making the patent easier to challenge.

Will Estoppel hurt me later?

Estoppel can hurt your patent later. After a final written decision in IPR or PGR, the petitioner may be estopped from raising in court grounds that were raised or reasonably could have been raised in the PTAB proceeding. Estoppel should be part of the strategy discussion before filing.

Do pre-AIA patents follow different rules?

Yes. Prior art rules differ for patents with effective filing dates before March 16, 2013. Always confirm whether pre-AIA or AIA rules apply before building an invalidity strategy.

Do I always need to invalidate a patent?

No. Sometimes the better option is to prove that the patent doesn’t cover your product, design around the claims, negotiate a license, wait for expiration, or challenge only the claims that create actual business risk.

Final Thoughts

Learning how to invalidate a patent starts with strategy, including dates, claims, evidence, forum, and business goals, all of which matter.

A strong patent invalidity plan begins by confirming whether the patent actually covers the product or activity at issue. From there, the challenger should identify the best grounds, choose the right forum, build a claim-by-claim evidence record, and account for deadlines and estoppel.

While weak claims don’t always survive scrutiny, the path to invalidation is rarely one-size-fits-all. Partner with the experienced team at Goldstein Patent Law to build a custom, watertight strategy that shields your business and decisively clears your path forward.